Cost-benefit analysis of screening for toxoplasmosis during pregnancy.

Cost-benefit analysis of screening for toxoplasmosis during pregnancy.

Item
http://www.wikidata.org/entity/Q50609926
Toxoplasma gondii: from animals to humansCongenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-savingIs screening for Chlamydia trachomatis infection cost effective?Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues.Methodological limitations of economic evaluations of antenatal screening.Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.Congenital toxoplasmosis and prenatal care state programs.Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological studyScreening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?Assessing value-for-money in maternal and newborn health.
P2860

Cost-benefit analysis of screening for toxoplasmosis during pregnancy.

Item
http://www.wikidata.org/entity/Q50609926
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@en
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@nl
type
label
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@en
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@nl
prefLabel
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@en
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921